Centerline Biomedical has completed two additional preclinical studies, which assessed its Intra-Operative Positioning System (IOPS).
The studies showed next-generation surgical navigation system’s ability to track catheters and guidewires precisely with enhanced 3D visualization.
Developed by Cleveland Clinic, the IOPS uses a 3D model of a patient's vascular system to track instruments precisely without X-ray exposure, helping to reduce procedure times, complication rates, and costs.
IOPS is a 3D GPS-like surgical navigation technology, which has been developed to reduce radiation exposure for both patients and caregivers and improve outcomes for endovascular procedures
The studies were conducted under the leadership of Cleveland Clinic surgeon Dr Matthew Eagleton.
Eagleton said: "This second round of work verified our ability to navigate the aorta and its branches, selecting the celiac artery, superior mesenteric artery, and renal arteries with the use of fluoroscopy limited to verification of catheter location.
“This technology will limit the need for extensive fluoroscopy units and provide more detailed anatomy that can be imaged while navigating through it. It will revolutionize vascular surgery."
Centerline chairman and CEO Dr Jai Gupta said: "The successful completion of this round of studies advances our mission to commercialize this highly innovative technology.
“These studies represent a key step in taking us to FDA submission with market entry targeted later next year."
Established in 2014, Centerline is a joint venture of G2 Group Ventures and Cleveland Clinic.
Image: Navigation through aorta using IOPS. Photo: courtesy of PRNewsFoto/Centerline Biomedical.